Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study

QUESTIONS UNDER STUDY: The differentiation between infectious and noninfectious pulmonary complications is challenging. Rapid, accurate microbiological results may allow appropriate antibiotic therapy, withholding or adapting antibiotics, and thus reducing costs and risks of empirical antibiotic t...

Full description

Bibliographic Details
Main Authors: Kathleen Jahn, Marko Kuisma, Minna Mäki, Peter Grendelmeier, Hans H. Hirsch, Michael Tamm, Eleni Papakonstantinou, Daiana Stolz
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2015-09-01
Series:Swiss Medical Weekly
Subjects:
Online Access:https://www.smw.ch/index.php/smw/article/view/2081
_version_ 1811289175354245120
author Kathleen Jahn
Marko Kuisma
Minna Mäki
Peter Grendelmeier
Hans H. Hirsch
Michael Tamm
Eleni Papakonstantinou
Daiana Stolz
author_facet Kathleen Jahn
Marko Kuisma
Minna Mäki
Peter Grendelmeier
Hans H. Hirsch
Michael Tamm
Eleni Papakonstantinou
Daiana Stolz
author_sort Kathleen Jahn
collection DOAJ
description QUESTIONS UNDER STUDY: The differentiation between infectious and noninfectious pulmonary complications is challenging. Rapid, accurate microbiological results may allow appropriate antibiotic therapy, withholding or adapting antibiotics, and thus reducing costs and risks of empirical antibiotic therapy. The objective of this proof-of-concept pilot study was to investigate the diagnostic yield of a new polymerase chain-reaction (PCR) and microarray-based rapid molecular diagnostic assay and compare the results to conventional microbiology cultures and clinical judgment. METHODS: Bronchoalveolar lavage specimens were obtained from 35 patients undergoing bronchoscopy for diagnostic reasons. Cases (n = 22) consisted of patients with suspicion of pulmonary bacterial infection. Controls (n = 13) were identified among patients undergoing bronchoscopy for indications other than suspicion of infection. RESULTS: Demographics were similar in cases and controls. The majority (73%) of patients with pulmonary infection were on empirical antibiotic therapy. Among the 22 cases, bacteria were identified by means of PCR in 77% (n = 17) as compared with 41% (n = 9) by culture (p = 0.030). In contrast, controls yielded a PCR positive result in 45% (n = 7), as compared with no positive cultures (p = 0.005). Compared with culture results, PCR had a sensitivity of 87.5% (95% confidence interval [CI] 47.4–97.9) and specificity of 28.6% (95% CI 8.6–58.1) to diagnose bacterial infection. Compared with clinical judgment, corresponding figures were 77.3% (95% CI 54.5–91.1) and 46.2% (95% CI 19.3–74.8), respectively. CONCLUSION: The PCR- and microarray-based rapid molecular diagnostic assay offers an alternative to conventional cultures for detection of potentially pathogenic bacteria in bronchoalveolar lavage of patients with pneumonia. However, the clinical relevance is unclear as it may also detect colonisers in patients without a corresponding infection.
first_indexed 2024-04-13T03:50:14Z
format Article
id doaj.art-91dcba3d40f34101a744ae55075e43fb
institution Directory Open Access Journal
issn 1424-3997
language English
last_indexed 2024-04-13T03:50:14Z
publishDate 2015-09-01
publisher SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
record_format Article
series Swiss Medical Weekly
spelling doaj.art-91dcba3d40f34101a744ae55075e43fb2022-12-22T03:03:51ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972015-09-01145394010.4414/smw.2015.14193Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot studyKathleen JahnMarko KuismaMinna MäkiPeter GrendelmeierHans H. HirschMichael TammEleni PapakonstantinouDaiana Stolz QUESTIONS UNDER STUDY: The differentiation between infectious and noninfectious pulmonary complications is challenging. Rapid, accurate microbiological results may allow appropriate antibiotic therapy, withholding or adapting antibiotics, and thus reducing costs and risks of empirical antibiotic therapy. The objective of this proof-of-concept pilot study was to investigate the diagnostic yield of a new polymerase chain-reaction (PCR) and microarray-based rapid molecular diagnostic assay and compare the results to conventional microbiology cultures and clinical judgment. METHODS: Bronchoalveolar lavage specimens were obtained from 35 patients undergoing bronchoscopy for diagnostic reasons. Cases (n = 22) consisted of patients with suspicion of pulmonary bacterial infection. Controls (n = 13) were identified among patients undergoing bronchoscopy for indications other than suspicion of infection. RESULTS: Demographics were similar in cases and controls. The majority (73%) of patients with pulmonary infection were on empirical antibiotic therapy. Among the 22 cases, bacteria were identified by means of PCR in 77% (n = 17) as compared with 41% (n = 9) by culture (p = 0.030). In contrast, controls yielded a PCR positive result in 45% (n = 7), as compared with no positive cultures (p = 0.005). Compared with culture results, PCR had a sensitivity of 87.5% (95% confidence interval [CI] 47.4–97.9) and specificity of 28.6% (95% CI 8.6–58.1) to diagnose bacterial infection. Compared with clinical judgment, corresponding figures were 77.3% (95% CI 54.5–91.1) and 46.2% (95% CI 19.3–74.8), respectively. CONCLUSION: The PCR- and microarray-based rapid molecular diagnostic assay offers an alternative to conventional cultures for detection of potentially pathogenic bacteria in bronchoalveolar lavage of patients with pneumonia. However, the clinical relevance is unclear as it may also detect colonisers in patients without a corresponding infection. https://www.smw.ch/index.php/smw/article/view/2081molecular diagnosticsbacterial infectionsbronchoalveolar lavagePCRclinical judgment
spellingShingle Kathleen Jahn
Marko Kuisma
Minna Mäki
Peter Grendelmeier
Hans H. Hirsch
Michael Tamm
Eleni Papakonstantinou
Daiana Stolz
Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study
Swiss Medical Weekly
molecular diagnostics
bacterial infections
bronchoalveolar lavage
PCR
clinical judgment
title Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study
title_full Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study
title_fullStr Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study
title_full_unstemmed Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study
title_short Molecular diagnostics for bacterial infections in bronchoalveolar lavage – a case-control, pilot study
title_sort molecular diagnostics for bacterial infections in bronchoalveolar lavage a case control pilot study
topic molecular diagnostics
bacterial infections
bronchoalveolar lavage
PCR
clinical judgment
url https://www.smw.ch/index.php/smw/article/view/2081
work_keys_str_mv AT kathleenjahn moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy
AT markokuisma moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy
AT minnamaki moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy
AT petergrendelmeier moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy
AT hanshhirsch moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy
AT michaeltamm moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy
AT elenipapakonstantinou moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy
AT daianastolz moleculardiagnosticsforbacterialinfectionsinbronchoalveolarlavageacasecontrolpilotstudy